{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:03:24Z","timestamp":1772136204766,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Grant for Cross-disciplinary Collaboration, Juntendo University","award":["2019-46"],"award-info":[{"award-number":["2019-46"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Mycobacterium abscessus<\/jats:italic>\n                    species (MABS) is the most commonly isolated rapidly growing mycobacteria (RGM) and is one of the most antibiotic-resistant RGM with rapid progression, therefore, treatment of MABS is still challenging. We here presented a new combination treatment with sitafloxacin that targeted rough morphotypes of MABS\n                    <jats:italic>,<\/jats:italic>\n                    causing aggressive infections. Thirty-four clinical strains of MABS were isolated from various clinical samples at the Juntendo university hospital from 2011 to 2020. The susceptibility to a combination of sitafloxacin and antimicrobial agents was compared to that of the antimicrobial agents alone. Out of 34 MABS, 8 strains treated with sitafloxacin\u2013amikacin combination, 9 of sitafloxacin\u2013imipenem combination, 19 of sitafloxacin\u2013arbekacin combination, and 9 of sitafloxacin\u2013clarithromycin combination showed synergistic effects, respectively. Sitafloxacin\u2013arbekacin combination also exhibited the synergistic effects against 10 of 22\n                    <jats:italic>Mycobacterium abscessus<\/jats:italic>\n                    subspecies\n                    <jats:italic>massiliense<\/jats:italic>\n                    (Mma) strains and 8 of 11\n                    <jats:italic>Mycobacterium abscessus<\/jats:italic>\n                    subspecies\n                    <jats:italic>abscessus<\/jats:italic>\n                    (Mab) strains\n                    <jats:italic>,<\/jats:italic>\n                    a highly resistant subspecies of MABS. The sitafloxacin\u2013arbekacin combination revealed more synergistic effects in rough morphotypes of MABS (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008). We demonstrated the synergistic effect of the sitafloxacin\u2013arbekacin combination against MABS. Further, this combination regimen might be more effective against Mab or rough morphotypes of MABS.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-29021-0","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T06:02:44Z","timestamp":1675490564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The synergetic effect of sitafloxacin\u2013arbekacin combination in the Mycobacterium abscessus species"],"prefix":"10.1038","volume":"13","author":[{"given":"Junko","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Handoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsaku","family":"Togo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Naito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Tabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"issue":"5","key":"29021_CR1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1164\/ajrccm\/147.5.1271","volume":"147","author":"DE Griffith","year":"1993","unstructured":"Griffith, D. E., Girard, W. M. & Wallace Jr, R. J. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am. Rev. Respir. Dis. 147(5), 1271\u20131278 (1993).","journal-title":"Am. Rev. Respir. Dis."},{"issue":"11","key":"29021_CR2","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1128\/JCM.01175-12","volume":"50","author":"T Harada","year":"2012","unstructured":"Harada, T. et al. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J. Clin. Microbiol. 50(11), 3556\u20133561 (2012).","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"29021_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186826","volume":"12","author":"H Nagano","year":"2017","unstructured":"Nagano, H. et al. Causative species of nontuberculous mycobacterial lung disease and comparative investigation on clinical features of Mycobacterium abscessus complex disease: A retrospective analysis for two major hospitals in a subtropical region of Japan. PLoS ONE 12(10), e0186826 (2017).","journal-title":"PLoS ONE"},{"issue":"1","key":"29021_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/thoraxjnl-2015-207983","volume":"71","author":"RA Floto","year":"2016","unstructured":"Floto, R. A. et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: Executive summary. Thorax 71(1), 88\u201390 (2016).","journal-title":"Thorax"},{"issue":"Pt 10","key":"29021_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1099\/jmm.0.077164-0","volume":"63","author":"KA Harris","year":"2014","unstructured":"Harris, K. A. & Kenna, D. T. D. Mycobacterium abscessus infection in cystic fibrosis: Molecular typing and clinical outcomes. J. Med. Microbiol. 63(Pt 10), 1241\u20131246 (2014).","journal-title":"J. Med. Microbiol."},{"issue":"2","key":"29021_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jcf.2009.12.001","volume":"9","author":"CR Esther Jr","year":"2010","unstructured":"Esther, C. R. Jr., Esserman, D. A., Gilligan, P., Kerr, A. & Noone, P. G. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J. Cyst. Fibros. 9(2), 117\u2013123 (2010).","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"29021_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley, C. L. et al. Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin. Infect. Dis. 71(4), 905\u2013913 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"29021_CR8","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1128\/AAC.03112-15","volume":"60","author":"BE Ferro","year":"2016","unstructured":"Ferro, B. E. et al. Tigecycline is highly efficacious against Mycobacterium abscessus pulmonary disease. Antimicrob. Agents Chemother. 60(5), 2895\u20132900 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29021_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/AAC.02052-16","volume":"61","author":"B Yang","year":"2017","unstructured":"Yang, B. et al. Clofazimine-containing regimen for the treatment of Mycobacterium abscessus lung disease. Antimicrob. Agents Chemother. 61, 6 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"29021_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1513\/AnnalsATS.201307-231OC","volume":"11","author":"KN Olivier","year":"2014","unstructured":"Olivier, K. N. et al. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Ann. Am. Thorac. Soc. 11(1), 30\u201335 (2014).","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"29021_CR11","doi-asserted-by":"publisher","first-page":"dlab004","DOI":"10.1093\/jacamr\/dlab004","volume":"3","author":"T Asami","year":"2021","unstructured":"Asami, T. et al. Efficacy estimation of a combination of triple antimicrobial agents against clinical isolates of Mycobacterium abscessus subsp. abscessus in vitro. JAC Antimicrob. Resist. 3(1), dlab004 (2021).","journal-title":"JAC Antimicrob. Resist."},{"key":"29021_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12879-016-1689-6","volume":"16","author":"H Namkoong","year":"2016","unstructured":"Namkoong, H. et al. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: A case series. BMC Infect. Dis. 16, 396 (2016).","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"29021_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/jac\/45.4.437","volume":"45","author":"J Fung-Tomc","year":"2000","unstructured":"Fung-Tomc, J. et al. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. J. Antimicrob. Chemother. 45(4), 437\u2013446 (2000).","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"29021_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0924-8579(01)00473-3","volume":"19","author":"H Tomioka","year":"2002","unstructured":"Tomioka, H., Sano, C., Sato, K. & Shimizu, T. Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex. Int. J. Antimicrob. Agents 19(2), 139\u2013145 (2002).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"12","key":"29021_CR15","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1128\/AAC.43.12.3001","volume":"43","author":"H Tomioka","year":"1999","unstructured":"Tomioka, H. et al. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob. Agents Chemother. 43(12), 3001\u20133004 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"29021_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijantimicag.2010.12.014","volume":"37","author":"C Sano","year":"2011","unstructured":"Sano, C. et al. Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium. Int. J. Antimicrob. Agents 37(4), 296\u2013301 (2011).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"21","key":"29021_CR17","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1128\/JB.182.21.6177-6182.2000","volume":"182","author":"TM Eckstein","year":"2000","unstructured":"Eckstein, T. M., Inamine, J. M., Lambert, M. L. & Belisle, J. T. A genetic mechanism for deletion of the ser2 gene cluster and formation of rough morphological variants of Mycobacterium avium. J. Bacteriol. 182(21), 6177\u20136182 (2000).","journal-title":"J. Bacteriol."},{"key":"29021_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1128\/jb.83.4.819-827.1962","volume":"83","author":"GB Fregnan","year":"1962","unstructured":"Fregnan, G. B. & Smith, D. W. Description of various colony forms of mycobacteria. J. Bacteriol. 83, 819\u2013827 (1962).","journal-title":"J. Bacteriol."},{"issue":"15","key":"29021_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S1286-4579(00)01338-1","volume":"2","author":"ST Howard","year":"2000","unstructured":"Howard, S. T. & Byrd, T. F. The rapidly growing mycobacteria: Saprophytes and parasites. Microbes Infect. 2(15), 1845\u20131853 (2000).","journal-title":"Microbes Infect."},{"issue":"3","key":"29021_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1432-1033.1993.tb18103.x","volume":"215","author":"LM Lopez Marin","year":"1993","unstructured":"Lopez Marin, L. M., Laneelle, M. A., Prome, D. & Daffe, M. Structures of the glycopeptidolipid antigens of two animal pathogens: Mycobacterium senegalense and Mycobacterium porcinum. Eur. J. Biochem. 215(3), 859\u2013866 (1993).","journal-title":"Eur. J. Biochem."},{"key":"29021_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-2164-8-114","volume":"8","author":"F Ripoll","year":"2007","unstructured":"Ripoll, F. et al. Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae. BMC Genomics 8, 114 (2007).","journal-title":"BMC Genomics"},{"issue":"2","key":"29021_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1378\/chest.126.2.566","volume":"126","author":"SK Field","year":"2004","unstructured":"Field, S. K., Fisher, D. & Cowie, R. L. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 126(2), 566\u2013581 (2004).","journal-title":"Chest"},{"issue":"5","key":"29021_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s15010-004-4001-4","volume":"32","author":"D Wagner","year":"2004","unstructured":"Wagner, D. & Young, L. S. Nontuberculous mycobacterial infections: A clinical review. Infection 32(5), 257\u2013270 (2004).","journal-title":"Infection"},{"issue":"Suppl 3","key":"29021_CR24","doi-asserted-by":"publisher","first-page":"S461","DOI":"10.1086\/314804","volume":"179","author":"CR Horsburgh Jr","year":"1999","unstructured":"Horsburgh, C. R. Jr. The pathophysiology of disseminated Mycobacterium avium complex disease in AIDS. J. Infect. Dis. 179(Suppl 3), S461-465 (1999).","journal-title":"J. Infect. Dis."},{"issue":"Pt 6","key":"29021_CR25","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1099\/mic.0.28625-0","volume":"152","author":"ST Howard","year":"2006","unstructured":"Howard, S. T. et al. Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiology (Reading). 152(Pt 6), 1581\u20131590 (2006).","journal-title":"Microbiology (Reading)."},{"issue":"1","key":"29021_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1128\/JCM.01478-08","volume":"47","author":"E Catherinot","year":"2009","unstructured":"Catherinot, E. et al. Acute respiratory failure involving an R variant of Mycobacterium abscessus. J. Clin. Microbiol. 47(1), 271\u2013274 (2009).","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"29021_CR27","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.4049\/jimmunol.0802181","volume":"183","author":"ER Rhoades","year":"2009","unstructured":"Rhoades, E. R. et al. Mycobacterium abscessus glycopeptidolipids mask underlying cell wall phosphatidyl-myo-inositol mannosides blocking induction of human macrophage TNF-alpha by preventing interaction with TLR2. J. Immunol. 183(3), 1997\u20132007 (2009).","journal-title":"J. Immunol."},{"issue":"3","key":"29021_CR28","doi-asserted-by":"publisher","first-page":"e02101","DOI":"10.1128\/AAC.01782-17","volume":"62","author":"G Clary","year":"2018","unstructured":"Clary, G. et al. Mycobacterium abscessus smooth and rough morphotypes form antimicrobial-tolerant biofilm phenotypes but are killed by acetic acid. Antimicrob. Agents Chemother. 62(3), e02101 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"29021_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12866-020-02000-5","volume":"20","author":"S Takei","year":"2020","unstructured":"Takei, S. et al. The synergetic effect of imipenem\u2013clarithromycin combination in the Mycobacteroides abscessus complex. BMC Microbiol. 20(1), 316 (2020).","journal-title":"BMC Microbiol."},{"key":"29021_CR30","volume-title":"Antibiotics in Laboratory Medicine","author":"V Lorian","year":"1996","unstructured":"Lorian, V. Antibiotics in Laboratory Medicine 4th edn. (Williams & Wilkins, 1996).","edition":"4"},{"key":"29021_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2147\/IMCRJ.S321969","volume":"14","author":"K Takano","year":"2021","unstructured":"Takano, K. et al. Severe pulmonary Mycobacterium abscessus cases due to co-infection with other microorganisms well treated by clarithromycin and sitafloxacin in Japan. Int. Med. Case Rep. J. 14, 465\u2013470 (2021).","journal-title":"Int. Med. Case Rep. J."},{"issue":"8","key":"29021_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.420","volume":"8","author":"J Whang","year":"2017","unstructured":"Whang, J. et al. Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D. Cell Death Dis. 8(8), e3012 (2017).","journal-title":"Cell Death Dis."},{"issue":"10","key":"29021_CR33","doi-asserted-by":"publisher","first-page":"E943","DOI":"10.1073\/pnas.1321390111","volume":"111","author":"A Bernut","year":"2014","unstructured":"Bernut, A. et al. Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation. Proc. Natl. Acad. Sci. USA 111(10), E943-952 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"29021_CR34","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/IAI.00835-06","volume":"75","author":"E Catherinot","year":"2007","unstructured":"Catherinot, E. et al. Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. Infect Immun. 75(2), 1055\u20131058 (2007).","journal-title":"Infect Immun."},{"issue":"5","key":"29021_CR35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1128\/JCM.02592-06","volume":"45","author":"BE Jonsson","year":"2007","unstructured":"Jonsson, B. E. et al. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J. Clin. Microbiol. 45(5), 1497\u20131504 (2007).","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"29021_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1128\/JCM.39.2.816-819.2001","volume":"39","author":"M Sanguinetti","year":"2001","unstructured":"Sanguinetti, M. et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J. Clin. Microbiol. 39(2), 816\u2013819 (2001).","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"29021_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038420","volume":"7","author":"BJ Kim","year":"2012","unstructured":"Kim, B. J. et al. Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. PLoS ONE 7(6), e38420 (2012).","journal-title":"PLoS ONE"},{"issue":"3","key":"29021_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijantimicag.2013.04.029","volume":"42","author":"S Yoshida","year":"2013","unstructured":"Yoshida, S. et al. Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents. Int. J. Antimicrob. Agents 42(3), 226\u2013231 (2013).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"29021_CR39","volume-title":"Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes","author":"GL Woods","year":"2011","unstructured":"Woods, G. L. et al. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes (Clinical and Laboratory Standards Institute, 2011)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29021-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29021-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29021-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T06:18:28Z","timestamp":1675491508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29021-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29021"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29021-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-767954\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-767954\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2027"}}